PofoliaShared via Pofolia

New England Journal of Medicine· 2014Q1

Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes

Siddhartha Jaiswal, Pierre Fontanillas, Jason Flannick, Alisa K. Manning et al.

Short summary

Somatic mutations in blood cells, termed age-related clonal hematopoiesis, are detectable in nearly 10-18% of individuals over 70 and are linked to significantly increased risks of hematologic cancer, all-cause mortality, and cardiovascular events.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Clonal mutations in blood cells are detectable in 9.5% of individuals aged 70-79, rising to 18.4% in those aged 90-108.
  • The majority of these mutations occur in the DNMT3A, TET2, and ASXL1 genes.
  • Presence of these mutations is associated with an 11.1-fold increased risk of hematologic cancer.
  • Mutations are linked to a 1.4-fold increase in all-cause mortality and significantly higher risks of cardiovascular events.

AI-generated from the title and abstract; the full text is not read.

Abstract

BACKGROUND: The incidence of hematologic cancers increases with age. These cancers are associated with recurrent somatic mutations in specific genes. We hypothesized that such mutations would be detectable in the blood of some persons who are not known to have hematologic disorders. METHODS: We analyzed whole-exome sequencing data from DNA in the peripheral-blood cells of 17,182 persons who were unselected for hematologic phenotypes. We looked for somatic mutations by identifying previously characterized single-nucleotide variants and small insertions or deletions in 160 genes that are recurrently mutated in hematologic cancers. The presence of mutations was analyzed for an association with hematologic phenotypes, survival, and cardiovascular events. RESULTS: Detectable somatic mutations were rare in persons younger than 40 years of age but rose appreciably in frequency with age. Among persons 70 to 79 years of age, 80 to 89 years of age, and 90 to 108 years of age, these clonal mutations were observed in 9.5% (219 of 2300 persons), 11.7% (37 of 317), and 18.4% (19 of 103), respectively. The majority of the variants occurred in three genes: DNMT3A, TET2, and ASXL1. The presence of a somatic mutation was associated with an increase in the risk of hematologic cancer (hazard ratio, 11.1; 95% confidence interval [CI], 3.9 to 32.6), an increase in all-cause mortality (hazard ratio, 1.4; 95% CI, 1.1 to 1.8), and increases in the risks of incident coronary heart disease (hazard ratio, 2.0; 95% CI, 1.2 to 3.4) and ischemic stroke (hazard ratio, 2.6; 95% CI, 1.4 to 4.8). CONCLUSIONS: Age-related clonal hematopoiesis is a common condition that is associated with increases in the risk of hematologic cancer and in all-cause mortality, with the latter possibly due to an increased risk of cardiovascular disease. (Funded by the National Institutes of Health and others.).

The authors' abstract, as published at the source. New England Journal of Medicine, 2014 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Hematology

HematologyMedicine